iShares Biotechnology ETF Rating → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free IBB Stock Alerts $132.96 +2.31 (+1.77%) (As of 05/3/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial Media iShares Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy2.57Holdings in IBB have an aggregate rating of Moderate Buy based on 638 analyst ratings issued in the past year covering 50 companies (84.5% of the portfolio).IBB Aggregate Price Target$157.8418.71% UpsideHigh Prediction$205.38Average Prediction$157.84Low Prediction$115.66Holdings in IBB have an aggregate price target of $157.84 and a range of $115.66 to $205.38 covering 50 companies (84.5% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBB Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.54%AMGNAmgen$311.29+11.8%5 of 5 stars2.52$305.05 -2.0%21Earnings ReportAnalyst UpgradeInsider SellingNews CoverageGap UpHigh Trading Volume8.32%VRTXVertex Pharmaceuticals$401.08+0.2%4 of 5 stars2.48$430.86 7.4%23Upcoming EarningsAnalyst Upgrade8.23%REGNRegeneron Pharmaceuticals$957.00+2.1%4 of 5 stars2.70$977.77 2.2%20Analyst DowngradeInsider SellingNews Coverage8.17%GILDGilead Sciences$64.78-0.8%5 of 5 stars2.39$83.69 29.2%18Analyst ReportShort Interest ↓4.42%IQVIQVIA$223.39+0.6%5 of 5 stars2.80$257.57 15.3%15Analyst ReportNews Coverage3.71%MRNAModerna$125.00-0.5%3 of 5 stars2.25$129.55 3.6%16Earnings ReportAnalyst ReportInsider SellingNews Coverage2.98%BIIBBiogen$217.51+1.9%5 of 5 stars2.65$291.64 34.1%26Analyst Report2.73%MTDMettler-Toledo International$1,253.28+0.3%3 of 5 stars2.17$1,233.25 -1.6%6Upcoming Earnings2.00%ILMNIllumina$117.93-4.9%5 of 5 stars2.32$167.70 42.2%20Earnings ReportAnalyst DowngradeNews CoverageGap Up1.97%ALNYAlnylam Pharmaceuticals$152.33+1.3%5 of 5 stars2.59$215.88 41.7%17Earnings ReportAnalyst ReportNews CoverageGap Up1.95%ARGXargenx$388.20-1.3%3 of 5 stars2.71$528.16 36.1%21Upcoming EarningsNews Coverage1.93%BNTXBioNTech$92.72+0.5%3 of 5 stars2.30$120.40 29.9%10Upcoming EarningsNews Coverage1.88%WATWaters$321.25+1.8%3 of 5 stars1.88$298.67 -7.0%8Upcoming Earnings1.81%BMRNBioMarin Pharmaceutical$82.44-1.6%5 of 5 stars2.63$107.50 30.4%191.73%GMABGenmab A/S$29.72+7.2%3 of 5 stars2.38$48.50 63.2%13Analyst ReportShort Interest ↑News CoverageGap Down1.39%NBIXNeurocrine Biosciences$140.71+0.6%5 of 5 stars2.74$147.46 4.8%23Analyst Report1.27%INCYIncyte$53.76+1.3%5 of 5 stars2.47$74.93 39.4%17Analyst ReportAnalyst Revision1.24%CRLCharles River Laboratories International$233.47+1.6%5 of 5 stars2.64$253.23 8.5%11Upcoming EarningsAnalyst RevisionNews Coverage1.15%BGNEBeiGene$162.25+0.1%3 of 5 stars2.80$250.13 54.2%10Short Interest ↑Gap Up1.11%SRPTSarepta Therapeutics$133.66+2.3%4 of 5 stars2.79$156.60 17.2%14Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage1.11%UTHRUnited Therapeutics$262.40+1.7%5 of 5 stars2.90$308.78 17.7%10Earnings ReportAnalyst ReportInsider SellingNews CoveragePositive News1.05%TECHBio-Techne$77.29+2.2%4 of 5 stars2.82$80.50 4.2%11Earnings ReportDividend AnnouncementAnalyst ReportNews Coverage1.05%NTRANatera$96.98+3.5%2 of 5 stars3.00$86.40 -10.9%14Analyst UpgradeInsider SellingNews Coverage1.00%MEDPMedpace$392.57+0.4%5 of 5 stars2.80$443.00 12.8%5Insider Selling0.88%RGENRepligen$167.05+0.4%4 of 5 stars2.89$197.75 18.4%9Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage0.78%LEGNLegend Biotech$45.41-1.1%2 of 5 stars2.92$82.64 82.0%120.77%BRKRBruker$70.05-0.1%5 of 5 stars2.43$84.86 21.1%7Earnings ReportNews CoverageHigh Trading Volume0.74%ASNDAscendis Pharma A/S$137.20-2.8%2 of 5 stars2.88$173.25 26.3%8Analyst ReportShort Interest ↑News Coverage0.74%ITCIIntra-Cellular Therapies$68.80-2.2%5 of 5 stars2.90$90.17 31.1%10Upcoming Earnings0.72%EXELExelixis$21.90-1.0%5 of 5 stars2.63$26.33 20.2%16Earnings ReportAnalyst ReportAnalyst Revision0.72%CYTKCytokinetics$65.27+1.4%4 of 5 stars2.87$79.33 21.5%15Upcoming EarningsShort Interest ↑Gap Up0.67%PCVXVaxcyte$65.96+2.2%1 of 5 stars3.00$78.50 19.0%4Positive NewsGap Up0.59%IONSIonis Pharmaceuticals$41.97-2.6%4 of 5 stars2.69$56.08 33.6%13Upcoming EarningsPositive News0.58%BPMCBlueprint Medicines$107.19+0.2%1 of 5 stars2.47$94.87 -11.5%15Analyst ReportNews CoverageGap Up0.54%ROIVRoivant Sciences$11.39+1.3%4 of 5 stars2.90$16.90 48.4%10Positive NewsGap Up0.53%RVMDRevolution Medicines$40.20+2.6%3 of 5 stars3.10$41.20 2.5%10Upcoming EarningsInsider SellingGap Up0.51%HALOHalozyme Therapeutics$39.91+0.2%5 of 5 stars2.86$53.29 33.5%7Analyst Report0.51%APLSApellis Pharmaceuticals$47.46-0.1%4 of 5 stars2.87$77.40 63.1%15Upcoming EarningsOptions VolumeGap Up0.49%CRSPCRISPR Therapeutics$55.89+1.5%3 of 5 stars2.38$76.29 36.5%16Gap Up0.42%ALKSAlkermes$24.05+0.8%5 of 5 stars2.50$35.38 47.1%10Earnings ReportAnalyst ReportShort Interest ↓News Coverage0.42%KRYSKrystal Biotech$161.10+0.5%4 of 5 stars3.00$171.00 6.1%9Upcoming EarningsGap Up0.39%INSMInsmed$25.55-0.4%4 of 5 stars3.00$44.92 75.8%12Upcoming EarningsNews CoveragePositive NewsGap Up0.39%MDGLMadrigal Pharmaceuticals$229.84+6.4%4 of 5 stars2.73$356.73 55.2%11Upcoming EarningsGap Up0.36%RAREUltragenyx Pharmaceutical$42.75-1.0%4 of 5 stars2.92$88.08 106.0%12Earnings ReportAnalyst ReportNews CoverageGap Up0.35%BBIOBridgeBio Pharma$27.83+0.3%5 of 5 stars2.80$47.82 71.8%10Short Interest ↑News CoverageGap Up0.34%FTREFortrea$37.41+2.1%0 of 5 stars2.38$37.29 -0.3%8Upcoming EarningsNews CoveragePositive News0.33%CRNXCrinetics Pharmaceuticals$47.20+0.9%4 of 5 stars2.91$54.00 14.4%11Upcoming EarningsShort Interest ↑News CoveragePositive News0.32%FOLDAmicus Therapeutics$10.40-0.3%4 of 5 stars3.00$20.00 92.3%3Upcoming EarningsNews CoverageGap Up0.32%XENEXenon Pharmaceuticals$43.75+1.7%3 of 5 stars3.00$59.44 35.9%9Options VolumeNews CoveragePositive News0.31%BHVNBiohaven$40.69+2.0%3 of 5 stars3.00$52.13 28.1%8Upcoming EarningsGap Up This page (NASDAQ:IBB) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
